Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2006-12-28
- Last Posted Date
- 2015-02-16
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 10
- Registration Number
- NCT00416923
Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-12-28
- Last Posted Date
- 2012-12-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 35
- Registration Number
- NCT00416403
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
๐บ๐ธUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
๐บ๐ธDana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
- First Posted Date
- 2006-12-28
- Last Posted Date
- 2015-08-20
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 10
- Registration Number
- NCT00416819
Educational Program to Improve Heart Failure Outcomes in Adults Living in Rural Areas
- Conditions
- Interventions
- First Posted Date
- 2006-12-25
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 614
- Registration Number
- NCT00415545
- Locations
- ๐บ๐ธ
University of California, Davis, Davis, California, United States
๐บ๐ธWashoe Health Care System, Reno, Nevada, United States
๐บ๐ธUniversity of Kentucky, Lexington, Kentucky, United States
Pulmonary Rehabilitation in Patients With Fibrotic Interstitial Lung Disease
- Conditions
- First Posted Date
- 2006-12-22
- Last Posted Date
- 2008-01-15
- Lead Sponsor
- University of California, San Francisco
- Registration Number
- NCT00415272
- Locations
- ๐บ๐ธ
University of California at San Francisco, San Francisco, California, United States
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
- Conditions
- First Posted Date
- 2006-12-13
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 20
- Registration Number
- NCT00410774
- Locations
- ๐บ๐ธ
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-11-22
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 84
- Registration Number
- NCT00402285
- Locations
- ๐บ๐ธ
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Evaluating a Pediatric Asthma Management Education Program for Physicians
- Conditions
- Interventions
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2013-06-13
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 40
- Registration Number
- NCT00399984
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States
Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
- Conditions
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2020-07-28
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 35
- Registration Number
- NCT00390156
- Locations
- ๐บ๐ธ
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Sorafenib and RAD001 Renal Cell Carcinoma
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 21
- Registration Number
- NCT00384969
- Locations
- ๐บ๐ธ
University of California, San Francisco, San Francisco, California, United States